Entero Healthcar IPO: Issue Details, Open/Close Date | Research 360 by Motilal Oswal
Back arrow

Entero Healthcar



+15.15 (1.36%)

  • DRHP

Offer Price

₹ 1,600.00 Cr

Issue Size

₹ 13,838

Min Investment


Times Subscribed


Lot size

Time Line

  • 09
    Feb 2024
  • 13
    Feb 2024
  • 14
    Feb 2024
    Finalisation of Basis of Allotment
  • 15
    Feb 2024
    Initiation of Refunds
  • 15
    Feb 2024
    Transfer of Shares to Demat Account
  • 16
    Feb 2024
    Listing Date

Shares Offered

Number of Times Subscribed

Objects of the Offer

  • Benefit from healthcare products distribution market consolidation with strategic acquisitions

  • Strengthen market position through increases in customer base, wallet share and geographic penetration

  • Pursue comprehensive marketing and distribution collaborations with healthcare product manufacturers

  • Expand its product adjacencies, private label and service offerings

  • Continue to invest in and leverage its technology, scale and synergistic adjacencies to drive efficiencies and profitability

Products & Services

  • The Company`s primary line of business is in the distribution of healthcare products to retail pharmacies, hospitals and healthcare clinics in India.


  • The Company operates in the large and highly fragmented Indian healthcare products distribution market and expect to benefit from market consolidation.

  • The Company is one of India`s largest and fastest growing healthcare products distribution platforms.

  • The Company has a track record of inorganic expansion and integration to grow its geographic reach, revenues and scale.

  • The Company has a differentiated business model offering comprehensive and integrated commercial and supply chain solutions.

  • The Company has a proprietary technology platform with integrated business intelligence tools and solutions.


  • Since its inception, the company has completed a number of acquisitions of distributors in India to expand its business and increase its customer base, and may continue to complete more acquisitions in the future. However, its may be unable to realize the anticipated benefits of past or future acquisitions successfully. Further, if the company is unable to identify expansion opportunities or experience delays or other problems in implementing our strategy of inorganic growth, its business, financial condition, results of operations, cash flows and prospects may be adversely affected.

  • The company has experienced negative cash flows from operating, investing and financing activities in the past and may continue to do so in the future.

  • The company may incur losses and its reputation may be adversely affected by the return of the company products by customers, arising from the distribution of expired, unsafe, defective, ineffective or counterfeit products, and product spoilage, breakage and damage during transportation or in storage. Its may also be subject to product liability claims.

  • Its lenders have imposed certain restrictive conditions on it under the company financing arrangements, which may adversely affect its ability to conduct its business and impair the company future growth plans.

  • Its operations are subject to high working capital requirements, and have incurred substantial indebtedness. Its inability to maintain an optimal level of working capital or financing required may impact its operations and profitability adversely.

Company Promoters

Promoters Holding

Issue For IPO
Pre Holding


Post Holding


Top Promoters Holding


All values in Cr

Mar-2022 Mar-2023 Mar-2023 3-Yr trend
Revenue 2,522.07 (41.70%) 3,300.21 (30.90%) -1.86 (-)
Gross Profit 2,522.07 (41.70%) 3,300.21 (30.90%) -1.86 (-)
Net Income 2,522.07 (41.70%) 3,300.21 (30.90%) -1.86 (-)
Assets 2,522.07 (41.70%) 3,300.21 (30.90%) -1.86 (-)
Liabilities 2,522.07 (41.70%) 3,300.21 (30.90%) -1.86 (-)


Company Name Revenue (Cr) Net Profit (Cr) Assets (Cr) Liabilities (Cr) ROE EPS BVPS Current Ratio Debt to Assets
Entero Healthcare Solutions Ltd 3,300.21 -11.56 1,040.82 445.79 -1.86 -28.11 -166.80 3.80 0.42
Medplus Health Services Ltd 4,557.58 49.76 2,796.72 2,796.72 3.33 4.17 124.93 1.77 0.00

Book Running Managers

  • ICICI Securities Ltd
  • Dam Capital Advisors Ltd
  • Jefferies India Pvt Ltd
  • JM Financial Ltd
  • SBI Capital Markets Ltd

Registrar & Transfer Agent

Link Intime India Pvt Ltd

C-101 247 Park,
L B S Marg,
Vikhroli West - Mumbai-400083
Phone : 91-22-49186000 Fax: 91-22-49186060

Company Contact Information

Plot # I-35 Bldg-B Ind. Area,
Phase-I 13/7 Mathura Road,
Faridabad - 121003
Phone : 0129-4877300 Email : jayant.prakash@enterohealthcare.com www.enterohealthcare.com

Offer Related Information

Initial public offering of 12,725,244# equity shares of face value of Rs. 10 each ("Equity") of Entero Healthcare Solutions Limited (The "Company" or the "Issuer") for cash at a price of Rs. 1,258 per equity share including a share premium of Rs. 1,248 per equity share (the "Offer Price") aggregating to Rs. 1600.00# crores (the "Offer"). The offer comprises of a fresh issue of 7,955,769# equity shares by the company aggregating to Rs. 1000.00# crores (the "Fresh Issue") and an offer for sale of... More


  • No Data Found.

Download Our App On: